NIC vs. PRLD

Last updated Apr 1, 2026

Compare and contrast key facts about Nicolet Bankshares Inc. (NIC) and Prelude Therapeutics Incorporated (PRLD).

Performance

NIC vs. PRLD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Nicolet Bankshares Inc. (NIC) and Prelude Therapeutics Incorporated (PRLD). The values are adjusted to include any dividend payments, if applicable.

NIC vs. PRLD - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
NIC Nicolet Bankshares Inc.	22.78%	16.76%	31.91%	1.93%	-6.95%	29.24%	21.14%
PRLD Prelude Therapeutics Incorporated	17.93%	127.45%	-70.14%	-29.30%	-51.49%	-82.60%	173.09%

Fundamentals

EPS NIC : $14.69 PRLD : -$1.47
PS Ratio NIC : 2.86 PRLD : 24.77
Total Revenue (TTM) NIC : $533.43M PRLD : $10.50M
Gross Profit (TTM) NIC : $284.60M PRLD : $10.08M
EBITDA (TTM) NIC : $145.70M PRLD : -$118.57M

Returns By Period

In the year-to-date period, NIC achieves a 22.78% return, which is significantly higher than PRLD's 17.93% return.

NIC

• 1D: 2.45%
• 1M: -2.51%
• YTD: 22.78%
• 6M: 11.00%
• 1Y: 37.70%
• 3Y*: 34.62%
• 5Y*: 12.66%
• 10Y*: 14.98%

PRLD

• 1D: 11.40%
• 1M: 23.91%
• YTD: 17.93%
• 6M: 137.50%
• 1Y: 345.31%
• 3Y*: -15.66%
• 5Y*: -39.23%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

NIC vs. PRLD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NIC

NIC Risk / Return Rank: 76
NIC Sharpe Ratio Rank: 78
NIC Sortino Ratio Rank: 74
NIC Omega Ratio Rank: 72
NIC Calmar Ratio Rank: 78
NIC Martin Ratio Rank: 78

PRLD

PRLD Risk / Return Rank: 91
PRLD Sharpe Ratio Rank: 88
PRLD Sortino Ratio Rank: 94
PRLD Omega Ratio Rank: 94
PRLD Calmar Ratio Rank: 93
PRLD Martin Ratio Rank: 89

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NIC vs. PRLD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Nicolet Bankshares Inc. (NIC) and Prelude Therapeutics Incorporated (PRLD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	NIC	PRLD	Difference
Sharpe ratio Return per unit of total volatility	1.21	1.77	-0.56
Sortino ratio Return per unit of downside risk	1.83	3.37	-1.54
Omega ratio Gain probability vs. loss probability	1.23	1.47	-0.24
Calmar ratio Return relative to maximum drawdown	2.10	4.67	-2.58
Martin ratio Return relative to average drawdown	5.38	10.24	-4.86
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

NIC vs. PRLD - Sharpe Ratio Comparison

The current NIC Sharpe Ratio is 1.21, which is lower than the PRLD Sharpe Ratio of 1.77. The chart below compares the historical Sharpe Ratios of NIC and PRLD, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	NIC	PRLD	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.21	1.77	-0.56
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.42	-0.32	+0.74
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.48	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.53	-0.25	+0.79

Correlation

The correlation between NIC and PRLD is 0.19, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

NIC vs. PRLD - Dividend Comparison

NIC's dividend yield for the trailing twelve months is around 0.86%, while PRLD has not paid dividends to shareholders.

	TTM	2025	2024	2023
NIC Nicolet Bankshares Inc.	0.86%	1.02%	1.04%	0.93%
PRLD Prelude Therapeutics Incorporated	0.00%	0.00%	0.00%	0.00%

Drawdowns

NIC vs. PRLD - Drawdown Comparison

The maximum NIC drawdown since its inception was -44.31%, smaller than the maximum PRLD drawdown of -99.33%. Use the drawdown chart below to compare losses from any high point for NIC and PRLD.

Drawdown Indicators

	NIC	PRLD	Difference
Max Drawdown Largest peak-to-trough decline	-44.31%	-99.33%	+55.02%
Max Drawdown (1Y) Largest decline over 1 year	-17.88%	-70.10%	+52.22%
Max Drawdown (5Y) Largest decline over 5 years	-44.31%	-98.62%	+54.31%
Max Drawdown (10Y) Largest decline over 10 years	-44.31%	—	—
Current Drawdown Current decline from peak	-7.71%	-96.27%	+88.56%
Average Drawdown Average peak-to-trough decline	-11.23%	-84.85%	+73.62%
Ulcer Index Depth and duration of drawdowns from previous peaks	6.98%	32.01%	-25.03%

Volatility

NIC vs. PRLD - Volatility Comparison

The current volatility for Nicolet Bankshares Inc. (NIC) is 7.83%, while Prelude Therapeutics Incorporated (PRLD) has a volatility of 31.39%. This indicates that NIC experiences smaller price fluctuations and is considered to be less risky than PRLD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	NIC	PRLD	Difference
Volatility (1M) Calculated over the trailing 1-month period	7.83%	31.39%	-23.56%
Volatility (6M) Calculated over the trailing 6-month period	23.21%	152.44%	-129.23%
Volatility (1Y) Calculated over the trailing 1-year period	31.35%	196.97%	-165.62%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	30.25%	124.27%	-94.02%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	31.64%	122.12%	-90.48%

Financials